Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall neurontinAfter all the problems and side effects reported in the news, information on Neurontin has become much more widely available through media coverage. Originally, the FDA approved Neurontin was meant for the treatment of two conditions; the treatment of seizures caused by epilepsy; the treatment of nerve pain associated with a shingles outbreak. Neurontin is effective in helping to control partial seizures and convulsions in adults with epilepsy, and is also used to help relieve certain types of nerve pain, and may be prescribed for other nervous system disorders.
Dateline NBC aired a story in 2002 wherein a corporate whistleblower exposed a sub-division of Pfizer, who deliberately distorted information on Neurontin, putting lives at risk in what may be one of the biggest medical deceptions in history. Pfizer has since been paying heavy fines and settling nationwide lawsuit claims for its illegal and deceptive practices.
Information on Neurontin has been around since the mid 1980s, when the drug was approved by the FDA as an adjunct, or add-on, medication for the control of partial seizures due to epilepsy in 1994. Neurontin started being researched for many off-label uses in 1996 and had since been aggressively promoted and prescribed for a variety of off-label uses, many of which it was found to be ineffective in treating.
Prescriptions were given without information on Neurontin for bipolar disorder, pain syndromes, peripheral neuropathy, and diabetic neuropathy, treatment of epilepsy alone as mono-therapy, reflex sympathetic dystrophy, attention deficit disorder, restless leg syndrome, trigeminal neuralgia, post-hepatic neuralgia, essential tremor periodic limb movement, migraines, and drug and alcohol withdrawal.
The common side effects for Neurontin are generally mild, but some people taking it also experience decreased coordination, double or blurred vision, back and forth eye movements, persistent sore throat or fever, swelling of ankles, mental or mood changes, memory loss, or trouble speaking. Anyone experiencing any of the more serious side effects should consult with their doctor immediately for more information on Neurontin.
Those side effects may be minor compared with Neurontin''s most dangerous potential side effect, suicidal tendency. Children are particularly susceptible to this dangerous side effect, and more information on Neurontin should be reviewed before furthering treatment, for the child’s safety. Talk with your doctor right away and seek alternative treatment immediately if your child begins having behavioral problems, sudden mood or personality changes, hostility, and trouble concentrating with schoolwork, or suicidal or other destructive thoughts or behaviors.
Someone suffering from Neurontin side effects may be entitled to legal compensation from the drug manufacturer and distributor. If Neurontin side effects occurred in a patient who was not given the proper information on Neurontin for an off-label use, the manufacturers may be especially liable for side effects of the drug in non-epileptic patients. However, it is important to discuss the any extraordinary symptoms with your doctor before discontinuing use of Neurontin. Contact your doctor today for more information on Neurontin.
The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were th...
Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...
The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.
The se...